COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 1796: Articles 17951-17960  | Next

Prophylaxis for covid-19: living systematic review and network meta-analysis
Bartoszko, J. J., Siemieniuk, R. A., Kum, E., Qasim, A., Zeraatkar, D., Ge, L., Han, M. A., Sadeghirad, B., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A. J., Devji, T., Ghadimi, M., Honarmand, K., Izcovich, A., Khamis, A., Lamontagne, F., Loeb, M., Marcucci, M., McLeod, S. L., Motaghi, S., Murthy, S., Mustafa, R. A., Neary, J. D., Pardo-Hernandez, H., Rada, G., Rochwerg, B., Switzer, C., Tendal, B., Thabane, L., Vandvik, P. O., Vernooij, R. W., Viteri-Garcia, A., Wang, Y., Yao, L., Ye, Z., Guyatt, G. H., Brignardello-Petersen, R.
10.1101/2021.02.24.21250469 — Posted: 2021-02-26 Discussion: Onsite
Discovery of SARS-CoV-2 strain of P.1 lineage harboring K417T/ E484K / N501Y by whole genome sequencing in the city, Japan
Hirotsu, Y., Omata, M.
10.1101/2021.02.24.21251892 — Posted: 2021-02-26
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes
Li, Y., Schneider, A. M., Mehta, A., Sade-Feldman, M., Kays, K. R., Gentili, M., Charland, N. C., Gonye, A. L., Gushterova, I., Khanna, H. K., LaSalle, T. J., Lavin-Parsons, K. M., Lilley, B. M., Lodenstein, C. L., Manakongtreecheep, K., Margolin, J. D., McKaig, B. N., Parry, B. A., Rojas-Lopez, M., Russo, B. C., Sharma, N., Tantivit, J., Thomas, M. F., Regan, J., Flynn, J. P., Villani, A.-C., Hacohen, N., Goldberg, M. B., Filbin, M. R., Li, J. Z.
10.1101/2021.02.24.21252357 — Posted: 2021-02-26
Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death
Geldsetzer, P., Mukama, T., Jawad, N. K., Riffe, T., Rogers, A., Sudharsanan, N.
10.1101/2021.02.23.21252314 — Posted: 2021-02-26
An empirical analysis of what people learned about COVID-19 through a web search and the impacts on misinformation and attitude towards public health safety guidelines.
Akpan, I. J., Aguolu, O. G., Akpan, A. A.
10.1101/2021.02.23.21252323 — Posted: 2021-02-26
Long COVID neuropsychological deficits after severe, moderate or mild infection
Voruz, P., Allali, G., Benzakour, L., Nuber-Champier, A., Thomasson, M., Jacot, I., Pierce, J., Lalive, P., Lovblad, K.-O., Brallaird, O., Coen, M., Serratrice, J., Pugin, J., Ptak, R., Guessous, I., Landis, B., Assal, F., Peron, J. A.
10.1101/2021.02.24.21252329 — Posted: 2021-02-26
COVIDReady2 Study Protocol: Cross-sectional Survey of Medical Student Volunteering and Education During the COVID-19 Pandemic in the United Kingdom
Byrne, M. H. V., Ashcroft, J., Alexander, L., Wan, J. C. M., Arora, A., Brown, M. E. L., Harvey, A., Clelland, A., Schindler, N., Brassett, C., Allan, R., MedEd Collaborative
10.1101/2021.02.24.21252103 — Posted: 2021-02-26
Heterogeneous Mental Health Development During the COVID-19 Pandemic in the United Kingdom
Ellwardt, L., Praeg, P.
10.1101/2021.02.24.21251565 — Posted: 2021-02-26
A national mixed-mode seroprevalence random population-based cohort on SARS-CoV-2 epidemic in France: the socio-epidemiological EpiCov study
WARSZAWSKI, J., BAJOS, N., BARLET, M., de LAMBALLERIE, X., RAHIB, D., LYDIE, N., DURRLEMAN, S., SLAMA, R., SENG, R., RAYNAUD, P., LEDUC, A., BAGEIN, G., PALIOD, N., LEGLEYE, S., FAVRE-MARTINOZ, C., CASTELL, L., SILLARD, P., Meyer, L., BECK, F., The EPICOV study group
10.1101/2021.02.24.21252316 — Posted: 2021-02-26
Risk factors for increased COVID-19 case-fatality in the United States: A county-level analysis during the first wave
Millar, J. A., Dao, H. D. N., Stefopulos, M. E., Estevam, C. G., Fagan-Garcia, K., Taft, D. H., Park, C., Alruwaily, A., Desai, A. N., Majumder, M. S.
10.1101/2021.02.24.21252135 — Posted: 2021-02-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).